EN DE
Watch Noratis AG for free: we tell you when fair value or trend changes.
Data-driven stock valuation

Noratis AG (NUVA) fair value: what the stock is really worth

As of Nov 16, 2026: fair value (intrinsic value) of Noratis AG stock €0.39, price €0.18, upside +112.8%, quality 37 out of 100. Rating: strongly undervalued. Calculated from audited financials with 9 of our 26 valuation models and 37 quality factors, updated daily.

  1. Keep an eye on it?Free in your watchlist: 5 stocks without an account, 10 with one Yes, for free

Real Estate DE · ISIN DE000A2E4MK4

NA Noratis AG logo Thin data Nov 16, 2026

Noratis AG

NUVA · XETRA

Cheap (53% below fair value), but weak company and price moving sideways: meets 1 of 3 rules.

Get notified free when this changes
Fair value €0.3851 · Strongly undervalued 
Generates free cash flow 
Price moving sideways (no uptrend) 
Wide range: only €0.1029 in the cautious scenario. 
Changed on Nov 17: €0.0144 → €0.3851 
Quality 37/100 
Weak Growth (revenue 5y −2.4 %/yr in EUR) 
Loss-making · -30.4% net margin (TTM) 
High debt 
Trails peers (3/11) 
Narrow moat 19/100 · thin data
Thin data 
⚠ Dilution⚠ Thinly traded
Watch Noratis AG for free: we tell you when fair value or trend changes. Watch for free

What runs behind every stock

69 individual criteria per stock, every one traceable See the method →

Price vs Fair Value

€321.86 €0.1810 Fair Value €0.3851 Jan 2021 Nov 2026

White line = price, green steps = our fair value per fiscal year. As of Nov 16, 2026.

How to read this chart

60‑month range €0.1810 – €321.86 · fair‑value band €0.1029 – €0.7617 · the €0.1810 price screens below the €0.3851 fair value. As of Nov 16, 2026.

Follow Noratis in your weekly email

Every Wednesday you see whether Noratis is on track or worth a review, plus price against fair value. Free, up to 3 stocks.

We send you a confirmation link. Unsubscribe with one click.

Which stocks are undervalued right now? Check free Discover now →

Company profile

Noratis AG, a real estate company, invests in, develops, manages, and sells residential property portfolios in Germany. It primarily focuses on a portfolio of apartments and residential areas. The company also invests in retail store properties.

Show moreShow less

Noratis AG was founded in 2002 and is based in Eschborn, Germany.

Stock analysis

Noratis AG (NUVA) currently trades at €0.1810, while our model-based Fair Value estimate is €0.3851, implying the stock looks roughly 53% undervalued today.

Show more

Valuation

Bull case: the Multiples group reads highest at a median of €1.42 per share, and 8 of the 9 models we run sit above the €0.1810 price.

Bear case: the Asset-Based group reads lowest at €0.5600, and 1 of the 9 models stay below the price. Data coverage for this calculation is low.

Scenario range: €0.1029 (bear) to €0.7617 (bull), the price of €0.1810 sits inside it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.

Quality & growth

The Quality Score stands at 37/100 (below-average quality), in the Real Estate sector.

Weak Growth: Revenue growth is inconsistent: the periods point in different directions, so there is no trend to rely on.

Noratis AG reported revenue of €67.3M in FY2024 versus €28.7M in FY2020, a compound +23.7%/yr. Reported net income was −€28.1M in FY2024.

Key figures

Market cap €2.4M Micro · P/S ratio 0.04 · EPS (TTM) €−2.01 · Dividend yield 0.9% · Net margin −30.4% · Return on equity −34.8% · Return on assets (EBIT) 1.2% (5-year average) · Operating margin 10.3%.

Competitive moat

Our AI-assisted moat analysis scores the competitive advantage at 19 out of 100 (low confidence).

What moves the price

The share trades about 60% below its 52-week high and 1,624% above its 52-week low, currently above its 200-day average.

For context, the median of 10 Real Estate peers we cover trades at −5% fair-value upside, at 113%, NUVA screens cheaper than that median.

Fair Value models

Bear €0.1029 Fair Value €0.3851 Bull €0.7617
Price €0.1810 · Upside +112.8%
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above starts from their evidence-weighted blend, not from a single model. In cyclical trough or peak years, after dilution or a stock split it is adjusted afterwards, so it can sit above or below the models. Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. If a model's bull case is above four times its base value, the table shows that limit with a > sign (like the overall Bull above): beyond it no assumption holds. Coverage ⓘCoverage = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Best data coverage
FCF DCF €3.96 €10.59 €21.96 72
Growth DCF €3.84 €9.73 €19.40 70
5Y EBITDA Exit n/a €0.1300 >€0.5200 69
All 9 models by family
DCF Models
FCF DCF €3.96 €10.59 €21.96 72
5Y Revenue Exit €1.32 €4.92 €9.74 64
5Y EBITDA Exit n/a €0.1300 >€0.5200 69
10Y Revenue Exit €2.02 €5.73 €11.35 60
10Y EBITDA Exit €0.6700 €2.27 €4.33 61
Multiples
EV/Revenue n/a €1.42 €3.21 50
Asset-Based
NCAV (Graham) €0.3700 €0.5600 €0.7000 55
Growth DCF
Growth DCF €3.84 €9.73 €19.40 70
Rev-Margin DCF €1.07 €4.38 €8.63 64

The fair value above starts from this blend and is adjusted for dilution from new shares.

Open the full fair value analysis →

Quality Score breakdown

Overall quality 37/100

It rates the business: profits, how they develop, real cash, balance sheet, investing and share count.

Profitability 1
How much profit the company makes from its sales and capital
Quality Growth 37
Are margins and returns getting better?
Cashflow 100
Do the profits arrive as real cash?
Financial strength 5
Debt, balance sheet and risk of trouble
Investment 100
Does it invest with discipline instead of growing at any price?
Low Volatility 50
How calm the share price moves, does not count
Price momentum 2
Price momentum of the last 3 to 12 months, does not count
Near the 52-week high 0
Distance to the 52-week high, does not count
New shares 0
Buys back shares or issues new ones?

Open the full quality analysis →

Revenue & earnings trend

Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card. 21/100
Revenue growth is inconsistent: the periods point in different directions, so there is no trend to rely on.
Revenue growth 1 year
+10.7%
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
−3.1%
Revenue growth 5 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
−2.4%
Revenue growth 10 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+14.9%
Profit margin (trend) ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.
19.7% (2019) → −24.5% (2024)
What shareholders gained per year ⓘWe only publish this rate when it is defensible. Reason: fiscal 2024 is a loss year, no rate is defined from a loss
not computed

Watch NUVA, get fair value alerts →

Compare Noratis AG with another stock

Price, fair value, quality and upside side by side.

Free, no sign-up

Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Real Estate - Development · 490 stocks

Beats the industry median on 3/10 measures
Overall it trails its industry peers.
Valuation
Quality Score 37 · Bottom 25%
Fair Value upside +112.8% · Above median
Profitability
Return on assets −6.8% · Bottom 25%
Net margin (12 months) −30.4% · Bottom 25%
Operating margin (12 months) 10.3% · Below median
Growth and dividend
Revenue growth (quarter YoY) 8.2% · Above median
Dividend yield (12 months) 0.9% · Bottom 25%
Balance sheet
Debt / equity 5.32× · Highest 25%

Valuation Multiplesvs Real Estate - Development median · lower = cheaper

P/S (12 months) 0.04× · Cheapest 25%
EV/EBITDA 59.9× · Priciest 25%

Strength profile in five axes (Snowflake)

VALUEFUTUREPASTHEALTHDIVIDEND
This stock
VALUEFUTUREPASTHEALTHDIVIDEND
Sector peers
VALUE (fair-value potential)100 · sector 67
FUTURE (revenue growth)41 · sector 0
PAST (return on equity)0 · sector 17
HEALTH (low debt)0 · sector 83
DIVIDEND (yield)17 · sector 63

Context: sector, industry, market

Values & ESG

Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.

None of the checked exposures detected

Similar stocks

10 more Real Estate - Development stocks, each showing price versus our Fair Value estimate.

Explore undervalued stocks

More undervalued Real Estate stocks →

Try a ready-made strategy

Pick a strategy and jump into the live analysis with that exact screen applied.

🥇 Backtested Best 🏆 Big Names 💎 Quality on Sale 🚀 Profitable Growth 🧊 Quality Compounders 💵 Dividend Stars 📈 Strong Momentum 📉 Fallen Angels ⚖️ Deeply Undervalued 🔍 Small-Cap Gems 🏰 Moat at a Fair Price 💼 Insider Buying 🎩 Buffett-Style Quality 📚 Peter Lynch GARP 🧮 Greenblatt Magic Formula 🛡️ Graham Defensive

Discover tools

For bloggers & editors: embed code + live data

For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.

Noratis AG: fair value per Fair Value Calculator

Cite: Fair Value Calculator (2026). "Noratis AG Fair Value". https://www.fairvalue-calculator.com/stock/NUVA

Frequently asked questions

Is Noratis AG (NUVA) overvalued or undervalued?
As of Nov 16, 2026, our model estimates a fair value of €0.3851 versus a price of €0.1810, about +113% upside (undervalued).
What is the fair value of NUVA?
Our model-based fair value for Noratis AG is €0.3851 (as of Nov 16, 2026), built from audited fundamentals. The current price: €0.1810.
What is the quality score of NUVA?
Noratis AG has a Quality Score of 37/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for Noratis AG (NUVA)?
Our model-based price target is the fair value of €0.3851 (as of Nov 16, 2026) from 9 valuation models. Cautious scenario €0.1029, optimistic scenario €0.7617. It is a calculation from audited fundamentals, not an analyst target.
What is the Noratis AG stock forecast for 2026?
Our models put fair value at €0.3851, about +113% upside versus a price of €0.1810 (undervalued). Cautious scenario €0.1029, optimistic scenario €0.7617. The calculation is refreshed regularly with new filings.
What is the revenue of Noratis AG (NUVA)?
Noratis AG reported trailing-twelve-month revenue of about €68.3M (latest available figure, as of Nov 16, 2026).
Does Noratis AG pay a dividend?
Noratis AG currently shows a dividend yield of 0.85% relative to its recent price (as of Nov 16, 2026).
How much is the dividend of Noratis AG (NUVA)?
Noratis AG has a dividend yield of 0.9%.
What is the intrinsic value of Noratis AG (NUVA)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For Noratis AG it is €0.3851 per share (as of Nov 16, 2026), against a price of €0.1810. It is the blended result of 9 valuation models in 4 families (DCF Models, Multiples, Asset-Based, Growth DCF).
Is Noratis AG stock overvalued or undervalued in 2026?
As of Nov 16, 2026, NUVA trades below its calculated fair value: price €0.1810, fair value €0.3851, a gap of about +113% (undervalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of NUVA?
No. The price is what the market pays today (€0.1810); the fair value is what the company's own numbers justify (€0.3851). For Noratis AG the two are €0.2041 per share apart. That gap is exactly why we show both numbers side by side.
How much is Noratis AG worth?
The market values Noratis AG at about €2.4M (market capitalisation, as of Nov 16, 2026). Per share that is €0.1810; our models calculate a fair value of €0.3851 per share.
What do the bullish and bearish scenarios say about NUVA?
Our models span a range for Noratis AG: cautious scenario €0.1029, base €0.3851, optimistic €0.7617 per share (as of Nov 16, 2026, price €0.1810). The range comes from different growth and margin assumptions, not from analyst opinions.
How solid is the balance sheet of Noratis AG (NUVA)?
Balance-sheet figures for Noratis AG (as of Nov 16, 2026): return on equity −34.8%, debt of 5.32 per unit of equity. They feed the Quality Score of 37/100, which measures business quality independently of the share price.
How far is NUVA from its 52-week high?
Noratis AG trades at €0.1810, about 60% below its 52-week high of €0.4480 and 1,624% above the low of €0.0105 (as of Nov 16, 2026). Distance from the high says nothing about value: that is what the fair value of €0.3851 is for.
Which stocks are comparable to Noratis AG?
From the same area (Real Estate) we also value Sun Hung Kai Properties Limited, CK Asset Holdings, DLF Limited, Hongkong Land Holdings, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is Noratis AG stock attractive at the current price?
The data as of Nov 16, 2026: price €0.1810, calculated fair value €0.3851 (+113%), Quality Score 37/100, from 9 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of NUVA calculated?
We run Noratis AG through 9 models from 4 families: DCF Models, Multiples, Asset-Based, Growth DCF. Every model gets the same audited fundamentals; the fair value of €0.3851 builds on their evidence-weighted average, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 13.6% above its aggregate fair value. Noratis AG currently trades 53% below its own fair value, and the market average says nothing about that. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of Noratis AG (NUVA)?
The closing price on Nov 16, 2026 was €0.1810. Our model-based fair value is €0.3851, about +113% upside (undervalued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with Noratis AG right now?
The large discount to fair value meets weak quality (37/100). That raises the risk this is a value trap rather than a bargain. The model range is unusually wide (€0.1029 to €0.7617). The outcome hinges heavily on assumptions, so read the point estimate with caution. The large gap to fair value rests on thin data (low evidence): fewer applicable models and a shorter history. Read it with extra caution. As a real-estate business, asset- and dividend-based methods carry more weight here than a standard DCF.

Key figures of Noratis AG

How large is the market capitalisation of Noratis AG (NUVA)?
The market capitalisation of Noratis AG is €2.4M. The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of Noratis AG (NUVA)?
The price-to-sales ratio of Noratis AG is 0.04 (last twelve months). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What are the earnings per share of Noratis AG (NUVA)?
Earnings per share at Noratis AG are €−2.01. Earnings per share over the last twelve months: total profit spread across every single share.
What is the dividend yield of Noratis AG (NUVA)?
The dividend yield of Noratis AG is 0.9%. Yearly dividend relative to the share price. 3% pays 3 per 100 invested. Below: how much of profit is used for it.
What is the net margin of Noratis AG (NUVA)?
The net margin of Noratis AG is −30.4% (last twelve months). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the return on equity of Noratis AG (NUVA)?
The return on equity (ROE) of Noratis AG is −34.8% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of Noratis AG (NUVA)?
On an EBIT basis the return on assets of Noratis AG is 1.2% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of Noratis AG (NUVA)?
The operating margin of Noratis AG is 10.3% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at Noratis AG (NUVA)?
Revenue at Noratis AG is growing 8.2% versus a year earlier (3y avg −3.1%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How fast are earnings growing at Noratis AG (NUVA)?
Earnings per share at Noratis AG are down 86.7% versus a year earlier. How much earnings per share grew versus a year earlier.
How much free cash flow does Noratis AG (NUVA) generate?
The free cash flow of Noratis AG is €34.7M (fiscal year 2024). The cash truly left after running and investing in the business, this is what pays dividends and buybacks.
How much net debt does Noratis AG (NUVA) carry?
The net debt of Noratis AG is €344M (fiscal year 2024, ≈ 9.9 yrs of FCF). Debt minus cash on hand. The note shows how many years of free cash flow could in theory pay it off.
Free · no account needed

Watch Noratis AG in the live analysis

One click puts Noratis AG on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 27,000+ stock screener.

Watch for free →

Zero risk: nothing is ever charged. Your watchlist is yours, with or without an account.